Stifel Financial Corp Heron Therapeutics, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.71 - $3.06 $18,308 - $32,763	-10,707 Reduced 41.52%	15,081 $41,000
Q4 2023 Feb 12, 2024	SELL	$0.54 - $1.82 $4,009 - $13,513	-7,425 Reduced 22.36%	25,788 $43,000
Q3 2023 Nov 13, 2023	BUY	$0.97 - $1.8 $145 - $270	150 Added 0.45%	33,213 $34,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $1,771 - $4,596	-1,596 Reduced 4.6%	33,063 $38,000
Q1 2023 May 12, 2023	SELL	$1.51 - $3.25 $1,845 - $3,971	-1,222 Reduced 3.41%	34,659 $52,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $25,420 - $52,761	-11,298 Reduced 23.95%	35,881 $89,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $1,138 - $2,298	-428 Reduced 0.9%	47,179 $199,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $3,955 - $10,818	-1,720 Reduced 3.49%	47,607 $133,000
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $12,551 - $26,947	-2,711 Reduced 5.21%	49,327 $282,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $98,713 - $148,957	-11,822 Reduced 18.51%	52,038 $475,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $258,375 - $382,590	-25,506 Reduced 28.54%	63,860 $683,000
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $29,738 - $41,413	2,241 Added 2.57%	89,366 $1.39 Million
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $190,775 - $272,799	13,166 Added 17.8%	87,125 $1.41 Million
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $86,330 - $130,825	-5,909 Reduced 7.4%	73,959 $1.57 Million
Q3 2020 Nov 16, 2020	BUY	$13.67 - $17.77 $5,563 - $7,232	407 Added 0.51%	79,868 $1.18 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $710,833 - $1.4 Million	-65,274 Reduced 45.1%	79,461 $1.17 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $150,841 - $362,137	14,745 Added 11.34%	144,735 $1.69 Million
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $360,071 - $550,028	20,670 Added 18.91%	129,990 $3.05 Million
Q3 2019 Nov 13, 2019	BUY	$16.36 - $21.39 $14,053 - $18,374	859 Added 0.79%	109,320 $2.04 Million
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $874,569 - $1.35 Million	51,658 Added 90.94%	108,461 $2.03 Million
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $1.31 Million - $1.61 Million	56,803 New	56,803 $1.37 Million
Q3 2018 Nov 13, 2018	SELL	$30.0 - $40.85 $844,020 - $1.15 Million	-28,134 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $742,737 - $1.18 Million	28,134 New	28,134 $1.09 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account